IBM scientist Recognized as 2017 Quartz Africa Innovator for Cancer Research

JOHANNESBURG, May 5, 2017 /PRNewswire/ -- IBM (NYSE: IBM) scientist Geoffrey Siwo has been named a 2017 Quartz Africa Innovator for his work in mapping the way cancer spreads and how cancer cells originate within the body.

This is the 3^rd annual list of Quartz Africa Innovators. The latest list includes more than 30 Africans from 18 different countries.

Siwo told Quartz Africa editors that, "Understanding cancer will also equip us with an understanding of many areas of biology, and therefore ways of developing diagnostics and treatments for diseases beyond cancer."

He joined IBM's Research lab in Johannesburg, South Africa in 2015. Siwo is currently leading the data driven healthcare research at the lab which in addition to cancer, is also focused on tracking the spread of tuberculous and anti-malarial drug resistance. He will be presenting some of his latest research at the Turing Talks in Scotland on 13 June.

Siwo earned a PhD in Biological Sciences from the University of Notre Dame in 2014 for developing computational models for understanding malaria drug resistance. He performed his post-doctoral research at the University of Pennsylvania (Perelman School of Medicine) and Dartmouth College (Geisel School of Medicine).

Follow him @gsiwo

Contact:
Christopher Sciacca
IBM Research
 +41 44 72 48 443
cia@zurich.ibm.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ibm-scientist-recognized-as-2017-quartz-africa-innovator-for-cancer-research-300452678.html

SOURCE IBM